Picture BIO Deutschland German Biotech Days 2019 Würzburg 600x60px
Organisation › Details

Sequenom (Group)

Sequenom, Inc. (Nasdaq: SQNM) is a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions. Sequenom develops innovative technology, products and diagnostic tests that target and serve discovery and clinical research, and molecular diagnostics markets. The company was founded in 1994 and is headquartered in San Diego, California. *


Period Start 1994-01-01 established
Period End 2016-09-07 acquired
  Group LabCorp (Group)
  Today LabCorp (Group)
  Successor LabCorp (Group)
Product Industry genomics/genetics
Person Person van den Boom, Dirk (Sequenom 201607 CEO)
Region Region San Diego, CA
  Country United States (USA)
  Street 3595 John Hopkins Court
  City 92121-1331 San Diego, CA
  Tel +1-858-202-9000
    Address record changed: 2018-07-24
Basic data Employees n. a.
  Currency USD
  Annual sales 37,863,000 (revenues, total, consolidated (2009) 2009-12-31)
  Profit -71,012,000 (2009-12-31)
  Cash 42,681,000 (2009-12-31)
    * Document for �About Section�: Sequenom, Inc.. (12/22/10). "Press Release: Sequenom CMM Commences Pivotal Clinical Validation Study for Its SensiGene Trisomy 21 Laboratory Developed Test". San Diego, CA.
Record changed: 2018-10-31


Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

More documents for LabCorp (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture BIO Deutschland Biotech Investors Day BID 2019 Würzburg 600x60px

» top